Brunn: An open source laboratory information system for microplates with a graphical plate layout design process

BackgroundCompound profiling and drug screening generates large amounts of data and is generally based on microplate assays. Current information systems used for handling this are mainly commercial, closed source, expensive, and heavyweight and there is a need for a flexible lightweight open system for handling plate design, and validation and preparation of data.ResultsA Bioclipse plugin consisting of a client part and a relational database was constructed. A multiple-step plate layout point-and-click interface was implemented inside Bioclipse. The system contains a data validation step, where outliers can be removed, and finally a plate report with all relevant calculated data, including dose-response curves.ConclusionsBrunn is capable of handling the data from microplate assays. It can create dose-response curves and calculate IC50 values. Using a system of this sort facilitates work in the laboratory. Being able to reuse already constructed plates and plate layouts by starting out from an earlier step in the plate layout design process saves time and cuts down on error sources.

[1]  Elin Lindhagen,et al.  The Fluorometric Microculture Cytotoxicity Assay. Nat Protoc 3:1364 , 2008 .

[2]  Bert Gunter,et al.  Improved Statistical Methods for Hit Selection in High-Throughput Screening , 2003, Journal of biomolecular screening.

[3]  Ulrich Schopfer,et al.  Compound Hub: efficiency gains through innovative sample management processes. , 2007, Combinatorial chemistry & high throughput screening.

[4]  Catherine Quintero,et al.  Design and Implementation of an Automated Compound Management System in Support of Lead Optimization , 2009, Journal of biomolecular screening.

[5]  Egon L. Willighagen,et al.  Bioclipse: an open source workbench for chemo- and bioinformatics , 2007, BMC Bioinformatics.

[6]  K. Nilsson,et al.  Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance. , 1996, British Journal of Cancer.

[7]  Egon L. Willighagen,et al.  Towards interoperable and reproducible QSAR analyses: Exchange of datasets , 2010, J. Cheminformatics.

[8]  Brian L Claus,et al.  Discovery informatics: its evolving role in drug discovery. , 2002, Drug discovery today.

[9]  Egon L. Willighagen,et al.  Bioclipse 2: A scriptable integration platform for the life sciences , 2009, BMC Bioinformatics.

[10]  Egon L. Willighagen,et al.  XMPP for cloud computing in bioinformatics supporting discovery and invocation of asynchronous web services , 2009, BMC Bioinformatics.

[11]  David E Root,et al.  A flexible data analysis tool for chemical genetic screens. , 2004, Chemistry & biology.

[12]  Elin Lindhagen,et al.  The fluorometric microculture cytotoxicity assay , 2008, Nature Protocols.

[13]  Carole A. Goble,et al.  The design and realisation of the myExperiment Virtual Research Environment for social sharing of workflows , 2009, Future Gener. Comput. Syst..

[14]  Ola Spjuth,et al.  Use of historic metabolic biotransformation data as a means of anticipating metabolic sites using MetaPrint2D and Bioclipse , 2010, BMC Bioinformatics.

[15]  Egon L. Willighagen,et al.  Linking the Resource Description Framework to cheminformatics and proteochemometrics , 2011, J. Biomed. Semant..

[16]  Alvis Brazma,et al.  On the Importance of Standardisation in Life Sciences , 2001, Bioinform..

[17]  John P. Sullivan,et al.  Screensaver: an open source lab information management system (LIMS) for high throughput screening facilities , 2010, BMC Bioinformatics.

[18]  Thomas W. Astle.  Recollections of Early Microplate Automation , 2000 .

[19]  The academic pursuit of screening. , 2007, Nature chemical biology.